How Canadian researchers are using 'liquid biopsies' to find traces of tumours left after cancer treatment

Blood test shows promise for detecting testicular cancer when standard markers miss

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications. Testicular cancer most often affects adolescents and young adults, and it is highly treatable, especially [] The post Blood test shows promise for detecting testicular cancer when standard markers miss appeared first on Middle East News 247.

Can a blood test tell if cancer is returning? Research is underway

If the test, also known as a liquid biopsy, is positive, those patients could get additional experimental treatments, to try to prevent the cancer coming back.

A DNA test helping cancer patients beat the odds

A DNA test helping cancer patients beat the odds

Can a blood test tell patients if their cancer is coming back? Researchers are working on it

Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test can detect tiny amounts of cancer remaining after patients have been treated.

Kennedy’s HHS is sacrificing cancer cures for trial bar profits

In May, researchers reported something that would have sounded like science fiction a generation ago. In patients with high-risk melanoma, an experimental mRNA cancer therapy paired with an immunotherapy drug cut the risk of the cancer returning or killing them by nearly half. The same approach is now in late-stage trials for lung, kidney, and []

Ivermectin isn’t a cancer miracle drug, but influencers claim otherwise – here’s how to avoid sprinting past scientific evidence

Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it’s a safe or effective way to treat cancer in people. However, a June 2026 study put the topic back in the spotlight. After ...

Jon and Mindy Gray bet $55M on AI to catch cancer before it starts

A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The idea behind the gift is unusual enough to need its own word. Most cancer philanthropy funds treatment, the long campaign that begins once a tumour has announced itself. Jon [] This story continues at The Next Web

Revolutionary new AI smartphone app can spot deadly skin cancers

Revolutionary new AI smartphone app can spot deadly skin cancers

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Scoping Review Links Pesticide Exposure to Increased Risks of Childhood Leukemia and Brain Cancer

(NaturalNews) A scoping review published in the International Journal of Cancer on July 1, 2026, examined epidemiologic studies from 1980 to 2022 and found associat...

Tel Aviv University Researchers Identify Immune Process That May Fuel Cancer Growth

Researchers at Tel Aviv University’s Gray Faculty of [] The post Tel Aviv University Researchers Identify Immune Process That May Fuel Cancer Growth appeared first on The Media Line.

Countering Common Cancer Conspiracies

The so-called “war on cancer” is not only a miserable failure but has also become a monumental myth perpetuated by the Medical...Click to Keep Reading »

What's behind the push to make peptide therapies more readily available

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.

An Immune Cell Meant to Fight Cancer Gets Reprogrammed by Tumors to Help Them Instead

Tel Aviv University researchers found that macrophages, the immune cells that clear dead cancer cells, get reprogrammed to stimulate tumor blood vessel growth instead of fighting cancer. The Effero-seq technology used to track this process in real time may point toward a new class of therapeutic targets.

What 111,000 Women Taught Researchers About Breast Cancer Risk

A massive study links metabolic health to breast cancer risk.

Patches could replace needles in vaccines of the future

Australian researchers are part of a new study into tiny, dissolvable micro-needle patches that may one day be an alternative to traditional vaccine injections.

Antarctic Sea Creatures May Hold Key To Fighting Deadly Cancer

Scientists are growing increasingly optimistic about new frontiers in melanoma treatment, with two promising developments pointing toward unconventional sources for combating the deadliest form of skin cancer. The most recent breakthrough comes from the icy waters of Antarctica, where a team from the University of South Florida recently completed a six-week expedition to collect samples ...

Cancer Support Network Foundation donates GHC100,000 to Accra Regional Hospital

The Cancer Support Network Foundation, an NGO championing cancer awareness across Africa, on Thursday presented a GHC100,000 cheque and assorted consumables to the Paediatric Oncology Unit of the Greater Accra Regional Hospital, popularly known as Ridge Hospital.

Once a source of national pride, Cuba’s healthcare system declines as energy shortages deepen crisis

BATABANO, Cuba — After two surgeries and several rounds of radiation therapy over the past four years to treat a tumor, Irisleydis Tristá has spent the past seven months unable to get a CT scan to determine whether the cancer has grown or spread. The CT scanner at Havana’s Hermanos Ameijeiras Hospital, the country’s leading hospital, is []

Scientists FINALLY work out what increases the risk of early-age bowel cancer - shedding a light on the mysterious rise in cases in under 50s

Scientists FINALLY work out what increases the risk of early-age bowel cancer - shedding a light on the mysterious rise in cases in under 50s

Doctors Discover What’s Behind the Disturbing Rise of Cancer Cases in Millennials and Gen Z

Cancer keeps striking younger and younger. We now know why.

Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight

Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight

EDX Medical to provide cancer profiling service to Astron Health

EDX Medical to provide cancer profiling service to Astron Health

No evidence of tumor cluster at Newton-Wellesley Hospital after 11 reported tumors in nurses, external review finds

The review found that the hospital's facility did not cause the tumors. The post No evidence of tumor cluster at Newton-Wellesley Hospital after 11 reported tumors in nurses, external review finds appeared first on Boston.com.

No more painful biopsies? How a new blood test will transform cancer detection in Hong Kong

In the fourth instalment of a six-part Health Matters wellness series on cancer in Hong Kong, Elizabeth Cheung examines how city researchers are developing new blood tests to detect the disease earlier, and what they could mean for screenings and diagnoses. Retired Hong Kong businessman Peter Wan Ying-keung still remembers the uncertainty and discomfort of his months-long journey to a prostate cancer diagnosis 13 years ago. It began with a routine blood test in 2013 that showed elevated levels...

One Blood Test Could Detect 50 Cancers at Once — the FDA Decision That Could Change Screening Forever

GRAIL's Galleri blood test may detect up to 50 cancers in one vial. The FDA is reviewing a premarket approval application submitted in January 2026. Here's what you need to know.

Why does cancer seem so common right now? An oncologist explains

Why does cancer seem so common right now? An oncologist explains

Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript

Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript

I survived testicular cancer — then I lost the friend who truly understood

'You question why you got to live and others haven’t.'

‘Absolutely non-negotiable’: The affordable products a dermatologist swears by

Dermatologist Cara McDonald shares the beauty items on her shelf.

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.